NT-proBNP Quantitative Test Reagent
N-terminal pro-brain natriuretic peptide (NT-proBNP), mainly derived from the ventricle, is a substance released by myocardial tissue when blood pressure and ventricular wall pressurerise. It is mainly used to evaluate myocardial function. Clinically, NT-proBNP is more stable,and higher concentrations are associated with higher heart disease severity.
Features:
● Animal: Canine, Feline
●Sample type: Plasma, Serum
●Sample volume: 75μL
●Detection range: 5 ~ 50000 pg/mL
● Reaction time: 15 min
● 4-30°storage, 24 months shelf life
TEST ITEM | SAMPLE TYPE/SAMPLE VOLUME | MIXTURE VOLUME | INCUBATION TIME | SIGNIFICANCES AND APPLICATIONS | RESULT INTERPRETATION | Specificity | Sensitivity | Detection range | Accuracy/Correlation | ||||
cNT-proBNP | Serum/(EDTA K2-Plasma) 75ul |
75uL | 15min | The precursor of amino terminal brain natriuretic peptide in dogs mainly comes from the ventricle, which is the substance released by myocardial tissue when blood pressure and ventricular wall pressure rise. Clinical application: differential diagnosis of dyspnea, diagnosis of congestive heart failure, evaluation of cardiac function, prognostic estimation and risk classification of cardiovascular diseases, and monitoring of therapeutic efficacy. |
cNT-proBNP | 96.78% | 5 pmol/L | 5-10000pmol/L | R2=0.95 | ||||
Significance | pg/mL | pmol/L | |||||||||||
low risk | <9490 | <900 | |||||||||||
Suspicion of MVD or DCM or cardiomegaly | >9490 | >900 | |||||||||||
high risk heart failure |
>18981 | >1800 | |||||||||||
fNT-proBNP | Serum/(EDTA K2-Plasma) 75ul |
fNT-proBNP | 100.00% | 50 pmol/L | 50-1500pmol/L | R2=0.95 | |||||||
Significance | pmol/L | ||||||||||||
Normal | <100 | ||||||||||||
Heart failure disease | 100-270 | ||||||||||||
Congestive heart failure | >270 |